Article
Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility.
International journal of molecular sciences - 3 Jan 2023
Meunier Lucy, Larrey Dominique
Abstract excerpt
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and the association with other autoimmune diseases is well-documented. There are many therapeutic options for the treatment of MS. Most of the available drugs cause drug-induced liver injury (DILI) to variable extents with heterogeneous clinical and biological manifestations, including liver injury with or without signs of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
